http://orcid.org/0000-0002-0052-7991
Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Yuhong Gan, Xiaobin Meng, Nanfeng Lei, Hong Yu, Qingkao Zeng & Qingyan Huang. (2023) Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients. Infection and Drug Resistance 16, pages 3989-3997.
Read now
Read now
Julie Gorham, Fabio Silvio Taccone & Maya Hites. (2022) Ensuring target concentrations of antibiotics in critically ill patients through dose adjustment. Expert Opinion on Drug Metabolism & Toxicology 18:3, pages 177-187.
Read now
Read now
Marco Fiore, Lorenzo Peluso, Fabio Silvio Taccone & Maya Hites. (2021) The impact of continuous renal replacement therapy on antibiotic pharmacokinetics in critically ill patients. Expert Opinion on Drug Metabolism & Toxicology 17:5, pages 543-554.
Read now
Read now
Alan Abdulla, Tim M.J. Ewoldt, Ilse M. Purmer, Anouk E. Muller, Diederik Gommers, Henrik Endeman & Birgit C.P. Koch. (2021) A narrative review of predictors for β-lactam antibiotic exposure during empirical treatment in critically ill patients. Expert Opinion on Drug Metabolism & Toxicology 17:4, pages 359-368.
Read now
Read now
Qi Wang, Zhanwei Wang, Feifei Zhang, Chunjiang Zhao, Bin Yang, Ziyong Sun, Yaning Mei, Feng Zhao, Kang Liao, Dawen Guo, Xiuli Xu, Hongli Sun, Zhidong Hu, Yunzhuo Chu, Yi Li, Ping Ji & Hui Wang. (2020) Long-Term Continuous Antimicrobial Resistance Surveillance Among Nosocomial Gram-Negative Bacilli in China from 2010 to 2018 (CMSS). Infection and Drug Resistance 13, pages 2617-2629.
Read now
Read now
Filippo Annoni, David Grimaldi & Fabio Silvio Taccone. (2020) Individualized antibiotic therapy in the treatment of severe infections. Expert Review of Anti-infective Therapy 18:1, pages 27-35.
Read now
Read now
Articles from other publishers (65)
Dhakrit Rungkitwattanakul, Taniya Charoensareerat, Ekanong Chaichoke, Thanakorn Rakamthong, Pitchaya Srisang, Sutthiporn Pattharachayakul, Nattachai Srisawat & Weerachai Chaijamorn. (2023) Piperacillin‐tazobactam dosing in anuric acute kidney injury patients receiving continuous renal replacement therapy. Seminars in Dialysis 36:6, pages 468-476.
Crossref
Crossref
Abi Jenkins, Conor Jamieson & Mark Santillo. (2023) Systematic review of room temperature stability of key beta-lactam antibiotics for extended infusions in inpatient settings. European Journal of Hospital Pharmacy, pages ejhpharm-2023-003855.
Crossref
Crossref
Alwin Tilanus & George Drusano. (2023) Optimizing the Use of Beta-Lactam Antibiotics in Clinical Practice: A Test of Time. Open Forum Infectious Diseases 10:7.
Crossref
Crossref
Yu-ying Yan, Yi Jin, Xiang-yuan Cao, Song-yu Chen, Wen-hao Liu, Chen-Rui Shen, Yu-shuang Qiu, Fu-ming Shen & Min Ni. (2023) A therapeutic regimen of ceftazidime-avibactam for a critical patient receiving prolonged intermittent renal replacement therapy. Journal of Infection and Chemotherapy 29:6, pages 620-623.
Crossref
Crossref
Amy Legg, Sinead Carmichael, Ming G. Chai, Jason A. Roberts & Menino O. Cotta. (2023) Beta-Lactam Dose Optimisation in the Intensive Care Unit: Targets, Therapeutic Drug Monitoring and Toxicity. Antibiotics 12:5, pages 870.
Crossref
Crossref
Sarah Dräger, Matthias von Rotz, Niklaus D Labhardt, Martin Siegemund, Katharina M Rentsch, Michael Osthoff & Fabian C Franzeck. (2023) Early Target Attainment With Continuous Infusion Meropenem and Piperacillin/Tazobactam and Utilization of Therapeutic Drug Monitoring in Critically Ill Patients: A Retrospective Cohort Study From 2017 to 2020. Open Forum Infectious Diseases 10:4.
Crossref
Crossref
Mohammadreza Salehi, Farah Rezazade-Moayed, Hossein Khalili, Homa Hemati, Nasser Aghdami, Mohadese Dashtkoohi, Mohammad Dashtkoohi, Mohammad-Taghi Beig-Mohammadi, Masoud Ramezani, Mahboobeh Hajiabdolbaghi & Samrand Fattah-Ghazi. (2023) Safety of megadose meropenem in the empirical treatment of nosocomial sepsis: a pilot randomized clinical trial. Future Microbiology 18:6, pages 335-342.
Crossref
Crossref
Johanne Gade Lilleøre, Andrea René Jørgensen, Martin Bruun Knudsen, Pelle Hanberg, Kristina Öbrink-Hansen, Sara Kousgaard Tøstesen, Kjeld Søballe, Maiken Stilling & Mats Bue. (2023) Steady-State Piperacillin Concentrations in the Proximity of an Orthopedic Implant: A Microdialysis Porcine Study. Antibiotics 12:3, pages 615.
Crossref
Crossref
Hans Christian Rasmussen, Pelle Hanberg, Martin Knudsen, Sara Kousgaard Tøstesen, Andrea René Jørgensen, Elisabeth Krogsgaard Petersen, Kristina Öbrink-Hansen, Kjeld Søballe, Maiken Stilling & Mats Bue. (2023) Piperacillin Steady State Concentrations in Target Tissues Relevant for PJI Treatment—A Randomized Porcine Microdialysis Study Comparing Continuous Infusion with Intermittent Short-Term Infusion. Antibiotics 12:3, pages 577.
Crossref
Crossref
Javier Martínez-Casanova, Erika Esteve-Pitarch, Helena Colom-Codina, Víctor Daniel Gumucio-Sanguino, Sara Cobo-Sacristán, Evelyn Shaw, Kristel Maisterra-Santos, Joan Sabater-Riera, Xosé L. Pérez-Fernandez, Raül Rigo-Bonnin, Fe Tubau-Quintano, Jordi Carratalà & Ariadna Padullés-Zamora. (2023) Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients. Antibiotics 12:3, pages 531.
Crossref
Crossref
Ashlan J Kunz Coyne, Amer El Ghali, Kristen Lucas, Paige Witucki, Nicholas Rebold, Dana J Holger, Michael P Veve & Michael J Rybak. (2023) High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production. Open Forum Infectious Diseases 10:3.
Crossref
Crossref
Xin He, Xiaoyan Liu, Xiaodan Gong, Li Wang & Feng Chen. (2023) Meropenem for the Pharmacological Treatment of Severe Infections in Critically Ill
Pediatric Patients: Breakthrough Standard Treatment Strategies Based on PK/PD. Current Drug Metabolism 24:1, pages 5-15.
Crossref
Crossref
Sui-Qing Ni, Wen-Bing Teng, Yong-Hong Fu, Wei Su, Zhi Yang, Jie Cai, Jin-Nuo Xu, Xiao-Ying Deng, Xiang-Fang Liu, Sheng-Nan Fu, Jun Zeng & Chen Zhang. (2022) The effect of a loading dose of meropenem on outcomes of patients with sepsis treated by continuous renal replacement: study protocol for a randomized controlled trial. Trials 23:1.
Crossref
Crossref
Elodie Matusik, Justine Lemtiri, Guillaume Wabont & Fabien Lambiotte. (2022) Beta-lactam dosing during continuous renal replacement therapy: a survey of practices in french intensive care units. BMC Nephrology 23:1.
Crossref
Crossref
Soo Min Jang, Susan J. Lewis & Sandy Jeong Rhie. (2022) Optimal antipseudomonal ꞵ-lactam drug dosing recommendations in critically-ill Asian patients receiving CRRT. Journal of Critical Care 72, pages 154172.
Crossref
Crossref
Xiao-Shan Zhang, Yu-Zhen Wang, Da-Wei Shi, Fang-Min Xu, Jun-Hui Yu, Jie Chen, Guan-Yang Lin, Chun-Hong Zhang, Xu-Ben Yu & Cong-Rong Tang. (2022) Efficacy and Pharmacodynamic Target Attainment for Ceftazidime–Avibactam Off-Label Dose Regimens in Patients with Continuous or Intermittent Venovenous Hemodialysis: Two Case Reports. Infectious Diseases and Therapy 11:6, pages 2311-2319.
Crossref
Crossref
Dana Bakdach, Reem Elajez, Abdul Rahman Bakdach, Ahmed Awaisu, Gennaro De Pascale & Ali Ait Hssain. (2022) Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on Obesity, Augmented Renal Clearance, Renal Replacement Therapies, and Extracorporeal Membrane Oxygenation. Journal of Clinical Medicine 11:23, pages 6898.
Crossref
Crossref
Ashlan J. Kunz Coyne, Mohammad Alshaer, Anthony M. Casapao, Veena Venugopalan, Carmen Isache, Jason Ferreira & Christopher A. Jankowski. (2022) Effectiveness and Safety of Beta-Lactam Antibiotics with and without Therapeutic Drug Monitoring in Patients with Pseudomonas aeruginosa Pneumonia or Bloodstream Infection. Antimicrobial Agents and Chemotherapy 66:10.
Crossref
Crossref
Shixing Zhu, Jiayuan Zhang, Zhihua Lv, Peijuan Zhu, Charles Oo, Mingming Yu & Sherwin K. B. Sy. (2022) Prediction of Tissue Exposures of Meropenem, Colistin, and Sulbactam in Pediatrics Using Physiologically Based Pharmacokinetic Modeling. Clinical Pharmacokinetics 61:10, pages 1427-1441.
Crossref
Crossref
Perrin Ngougni Pokem, Peter Matzneller, Steven Vervaeke, Xavier Wittebole, Lieven Goeman, Marie Coessens, Eleonora Cottone, Arnaud Capron, Beatrix Wulkersdorfer, Pierre Wallemacq, Johan W Mouton, Anouk E Muller, Markus Zeitlinger, Pierre François Laterre, Paul M Tulkens & Françoise Van Bambeke. (2022)
Binding of temocillin to plasma proteins
in vitro
and
in vivo
: the importance of plasma protein levels in different populations and of co-medications
. Journal of Antimicrobial Chemotherapy 77:10, pages 2742-2753.
Crossref
Crossref
Abdul Haseeb, Hani Saleh Faidah, Saleh Alghamdi, Amal F. Alotaibi, Mahmoud Essam Elrggal, Ahmad J. Mahrous, Safa S. Almarzoky Abuhussain, Najla A. Obaid, Manal Algethamy, Abdullmoin AlQarni, Asim A. Khogeer, Zikria Saleem, Muhammad Shahid Iqbal, Sami S. Ashgar, Rozan Mohammad Radwan, Alaa Mutlaq, Nayyra Fatani & Aziz Sheikh. (2022) Dose optimization of β-lactams antibiotics in pediatrics and adults: A systematic review. Frontiers in Pharmacology 13.
Crossref
Crossref
Elisabeth Krogsgaard Petersen, Pelle Hanberg, Martin Knudsen, Sara Kousgaard Tøstesen, Andrea René Jørgensen, Kristina Öbrink-Hansen, Kjeld Søballe, Maiken Stilling & Mats Bue. (2022) Intermittent Short-Term Infusion vs. Continuous Infusion of Piperacillin: Steady State Concentrations in Porcine Cervical Spine Tissue Evaluated by Microdialysis. Antibiotics 11:7, pages 910.
Crossref
Crossref
María Eugenia Navarrete-Rouco, Sònia Luque, Luisa Sorlí, Adela Benítez-Cano, Jason A. Roberts & Santiago Grau. (2022) Therapeutic Drug Monitoring and Prolonged Infusions of Ceftolozane/Tazobactam for MDR/XDR Pseudomonas aeruginosa Infections: An Observational Study. European Journal of Drug Metabolism and Pharmacokinetics 47:4, pages 561-566.
Crossref
Crossref
Eveline Wallenburg, Rob ter Heine, Jeroen A. Schouten, Jelmer Raaijmakers, Jaap ten Oever, Eva Kolwijck, David M. Burger, Peter Pickkers, Tim Frenzel & Roger J. M. Brüggemann. (2022) An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients. Clinical Pharmacokinetics 61:6, pages 907-918.
Crossref
Crossref
Timothy Luxton, Natalie King, Christoph Wälti, Lars Jeuken & Jonathan Sandoe. (2022) A systematic review of the effect of therapeutic drug monitoring on patient health outcomes during treatment with penicillins. Journal of Antimicrobial Chemotherapy 77:6, pages 1532-1541.
Crossref
Crossref
Eveline Wallenburg, Roger J.M. Brüggemann, Jason A. Roberts, Nynke G.L. Jager, Marta Ulldemolins, Sarah Wilkes, Jeroen Schouten, Paul K.L. Chin & Rob ter Heine. (2022) A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patients. Clinical Microbiology and Infection 28:3, pages 446.e1-446.e7.
Crossref
Crossref
Manawr AL-Quraini, Meher Rizvi, Zaaima AL-Jabri, Hiba Sami, Muna AL-Muzahmi, Zakariya AL-Muharrmi, Neelam Taneja, Ibrahim AL-Busaidi & Rajeev Soman. (2022) Assessment of In-Vitro Synergy of Fosfomycin with Meropenem, Amikacin and Tigecycline in Whole Genome Sequenced Extended and Pan Drug Resistant Klebsiella Pneumoniae: Exploring A Colistin Sparing Protocol. Antibiotics 11:2, pages 153.
Crossref
Crossref
Jongsung Hahn, Kyoung Lok Min, Soyoung Kang, Seungwon Yang, Min Soo Park, Jin Wi & Min Jung Chang. (2021) Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy. Microbiology Spectrum 9:3.
Crossref
Crossref
Paolo Gaibani, Milo Gatti, Matteo Rinaldi, Cristina Crovara Pesce, Tiziana Lazzarotto, Maddalena Giannella, Donatella Lombardo, Stefano Amadesi, Pierluigi Viale, Federico Pea & Simone Ambretti. (2021) Suboptimal drug exposure leads to selection of different subpopulations of ceftazidime-avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in a critically ill patient. International Journal of Infectious Diseases 113, pages 213-217.
Crossref
Crossref
Soo-Min Jang, Alex R. Shaw & Bruce A. Mueller. (2021) Size Matters: The Influence of Patient Size on Antibiotics Exposure Profiles in Critically Ill Patients on Continuous Renal Replacement Therapy. Antibiotics 10:11, pages 1390.
Crossref
Crossref
Soo Min Jang & Linda Awdishu. (2021) Drug dosing considerations in continuous renal replacement therapy. Seminars in Dialysis 34:6, pages 480-488.
Crossref
Crossref
Martin Knudsen, Mats Bue, Louise L. Pontoppidan, Magnus A. Hvistendahl, Kjeld Søballe, Maiken Stilling & Pelle Hanberg. (2021) Evaluation of Benzylpenicillin as an Internal Standard for Measurement of Piperacillin Bone Concentrations Via Microdialysis. Journal of Pharmaceutical Sciences 110:10, pages 3500-3506.
Crossref
Crossref
Soo Min Jang, Lenar Yessayan, Michael Dean, Gabrielle Costello, Ravi Katwaru & Bruce A. Mueller. (2021) Imipenem/Relebactam Ex Vivo Clearance during Continuous Renal Replacement Therapy. Antibiotics 10:10, pages 1184.
Crossref
Crossref
Tomas Urbina, Keyvan Razazi, Clément Ourghanlian, Paul-Louis Woerther, Olivier Chosidow, Raphaël Lepeule & Nicolas de Prost. (2021) Antibiotics in Necrotizing Soft Tissue Infections. Antibiotics 10:9, pages 1104.
Crossref
Crossref
Eveline Wallenburg, Rob ter Heine, Dylan W de Lange, Henk van Leeuwen, Jeroen A Schouten, Jaap ten Oever, Eva Kolwijck, David M Burger, Peter Pickkers, Emilie M Gieling, Monique M de Maat, Tim Frenzel & Roger J Brüggemann. (2021) High unbound flucloxacillin fraction in critically ill patients. Journal of Antimicrobial Chemotherapy.
Crossref
Crossref
Huili Zhang, Kairui Zhou, Xinglong He & Xin Yuan. (2021) Comparative study on the changes of bacterial species and severity of antimicrobial resistance during 13 years. PLOS ONE 16:8, pages e0256375.
Crossref
Crossref
E. Matusik, F. Lambiotte, A. Tone & J. Lemtir. (2021) Modifications pharmacocinétiques et optimisation pharmacocinétique/pharmacodynamique des bêta-lactamines en réanimation. Annales Pharmaceutiques Françaises 79:4, pages 346-360.
Crossref
Crossref
Sonia Luque, Adela Benítez-Cano, Leire Larrañaga, Luisa Sorlí, María Eugenia Navarrete, Nuria Campillo, Jesús Carazo, Isabel Ramos, Ramón Adalia & Santiago Grau. (2021) Pharmacokinetics and Pharmacodynamics of Meropenem by Extended or Continuous Infusion in Low Body Weight Critically Ill Patients. Antibiotics 10:6, pages 666.
Crossref
Crossref
Maya Hites. (2021) Minireview on Novel Anti-infectious Treatment Options and Optimized Drug Regimens for Sepsis. Frontiers in Medicine 8.
Crossref
Crossref
Selina Schießer, Florian Hitzenbichler, Martin G. KeesAlexander KratzerMatthias LubnowBernd Salzberger, Frieder Kees & Christoph Dorn. (2021) Measurement of Free Plasma Concentrations of Beta-Lactam Antibiotics: An Applicability Study in Intensive Care Unit Patients. Therapeutic Drug Monitoring 43:2, pages 264-270.
Crossref
Crossref
Christina Scharf, Uwe Liebchen, Michael Paal, Max Taubert, Michael Vogeser, Michael Irlbeck, Michael Zoller & Ines Schroeder. (2020) The higher the better? Defining the optimal beta-lactam target for critically ill patients to reach infection resolution and improve outcome. Journal of Intensive Care 8:1.
Crossref
Crossref
Tospon Lertwattanachai, Preecha Montakantikul, Viratch Tangsujaritvijit, Pitsucha Sanguanwit, Jetjamnong Sueajai, Saranya Auparakkitanon & Pitchaya Dilokpattanamongkol. (2020) Clinical outcomes of empirical high-dose meropenem in critically ill patients with sepsis and septic shock: a randomized controlled trial. Journal of Intensive Care 8:1.
Crossref
Crossref
Alan Abdulla, Annemieke Dijkstra, Nicole G. M. Hunfeld, Henrik Endeman, Soma Bahmany, Tim M. J. Ewoldt, Anouk E. Muller, Teun van Gelder, Diederik Gommers & Birgit C. P. Koch. (2020) Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT). Critical Care 24:1.
Crossref
Crossref
Athanasios Tsakris, Vasiliki Koumaki, Aristides Dokoumetzidis & Indran Balakrishnan. (2020) Monte Carlo simulation of temocillin 6 g daily administered by continuous infusion or intermittent dosage. Journal of Antimicrobial Chemotherapy 75:10, pages 3079-3080.
Crossref
Crossref
Isabelle K. Delattre, Maya Hites, Pierre-Francois Laterre, Thierry Dugernier, Herbert Spapen, Pierre E. Wallemacq, Frédérique Jacobs & Fabio Silvio Taccone. (2020) What is the optimal loading dose of broad-spectrum β-lactam antibiotics in septic patients? Results from pharmacokinetic simulation modelling. International Journal of Antimicrobial Agents 56:4, pages 106113.
Crossref
Crossref
Lingling Ye, Meng Ke, Xiang You, Pinfang Huang & Cuihong Lin. (2020) A Physiologically Based Pharmacokinetic Model of Ertapenem in Pediatric Patients With Renal Impairment. Journal of Pharmaceutical Sciences 109:9, pages 2909-2918.
Crossref
Crossref
Eveline Wallenburg, Rob ter Heine, Jeroen A. Schouten & Roger J.M. Brüggemann. (2020) Personalised antimicrobial dosing: standing on the shoulders of giants. International Journal of Antimicrobial Agents 56:3, pages 106062.
Crossref
Crossref
Ivana Kacířová & Milan Grundmann. (2020) Therapeutic drug monitoring. Klinická farmakologie a farmacie 34:2, pages 47-55.
Crossref
Crossref
Christina Scharf, Michael Paal, Ines Schroeder, Michael Vogeser, Rika Draenert, Michael Irlbeck, Michael Zoller & Uwe Liebchen. (2020) Therapeutic Drug Monitoring of Meropenem and Piperacillin in Critical Illness—Experience and Recommendations from One Year in Routine Clinical Practice. Antibiotics 9:3, pages 131.
Crossref
Crossref
Mats Bue, Tomás Sou, Anna Sophie L. Okkels, Pelle Hanberg, Anders Thorsted, Lena E. Friberg, Torben L. Andersson, Kristina Öbrink-Hansen & Steffen Christensen. (2020) Population pharmacokinetics of piperacillin in plasma and subcutaneous tissue in patients on continuous renal replacement therapy. International Journal of Infectious Diseases 92, pages 133-140.
Crossref
Crossref
Caroline Damen, Sofie Dhaese, Alain G. Verstraete, Veronique Stove & Jan J. De Waele. (2019) Subtherapeutic piperacillin concentrations in neurocritical patients. Journal of Critical Care 54, pages 48-51.
Crossref
Crossref
Paige Soukup, Andrew C. Faust, Vindhya Edpuganti, William C. Putnam & James A. McKinnell. (2019)
Steady‐State Ceftazidime‐Avibactam Serum Concentrations and Dosing Recommendations in a Critically Ill Patient Being Treated for
Pseudomonas aeruginosa
Pneumonia and Undergoing Continuous Venovenous Hemodiafiltration
. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39:12, pages 1216-1222.
Crossref
Crossref
Soo Min JangManjunath P. PaiAlexander R. ShawBruce A. Mueller. (2019) Antibiotic Exposure Profiles in Trials Comparing Intensity of Continuous Renal Replacement Therapy. Critical Care Medicine 47:11, pages e863-e871.
Crossref
Crossref
Chandra Datta Sumi, Aaron J. Heffernan, Jeffrey Lipman, Jason A. Roberts & Fekade B. Sime. (2019) What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram-Negative Bacteria? A Systematic Review. Clinical Pharmacokinetics 58:11, pages 1407-1443.
Crossref
Crossref
Sofie A.M. Dhaese, Alexander D.J. Thooft, Andras Farkas, Jeffrey Lipman, Alain G. Verstraete, Veronique Stove, Jason A. Roberts & Jan J. De Waele. (2019) Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational study. Journal of Critical Care 52, pages 75-79.
Crossref
Crossref
Nicholas Weber, Kathryn Jackson, Brett McWhinney, Jacobus Ungerer, Glen Kennedy, Jeffrey Lipman & Jason A. Roberts. (2019) Evaluation of pharmacokinetic/pharmacodynamic and clinical outcomes with 6-hourly empiric piperacillin-tazobactam dosing in hematological malignancy patients with febrile neutropenia. Journal of Infection and Chemotherapy 25:7, pages 503-508.
Crossref
Crossref
Olivia Smibert, Michael J. Satlin, Anoma Nellore & Anton Y. Peleg. (2019) Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplantation: Management Principles. Current Infectious Disease Reports 21:7.
Crossref
Crossref
Perrin Ngougni Pokem, Arnaud Capron, Pierre Wallemacq, Paul M Tulkens, Françoise Van Bambeke & Pierre-François Laterre. (2019) Temocillin plasma and pancreatic tissue concentrations in a critically ill patient with septic shock. Journal of Antimicrobial Chemotherapy 74:5, pages 1459-1461.
Crossref
Crossref
Sofie A M Dhaese, Andras Farkas, Pieter Colin, Jeffrey Lipman, Veronique Stove, Alain G Verstraete, Jason A Roberts & Jan J De Waele. (2019) Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic models. Journal of Antimicrobial Chemotherapy 74:2, pages 432-441.
Crossref
Crossref
Aaron J. Heffernan, Fekade B. Sime, Fabio S. Taccone & Jason A. Roberts. (2018) How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients. Current Opinion in Infectious Diseases 31:6, pages 555-565.
Crossref
Crossref
Sofie A.M. Dhaese, Magalie De Kezel, Maxime Callant, Jerina Boelens, Liesbet De Bus, Pieter Depuydt & Jan J. De Waele. (2018) Emergence of antimicrobial resistance to piperacillin/tazobactam or meropenem in the ICU: Intermittent versus continuous infusion. A retrospective cohort study. Journal of Critical Care 47, pages 164-168.
Crossref
Crossref
Alexandra Jacobs, Fabio Silvio Taccone, Jason A. Roberts, Frédérique Jacobs, Frederic Cotton, Fleur Wolff, Jacques Creteur, Jean-Louis Vincent & Maya Hites. (2018) β-Lactam Dosage Regimens in Septic Patients with Augmented Renal Clearance. Antimicrobial Agents and Chemotherapy 62:9.
Crossref
Crossref
Sofie A.M. Dhaese, Jason A. Roberts, Mieke Carlier, Alain G. Verstraete, Veronique Stove & Jan J. De Waele. (2018) Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients. International Journal of Antimicrobial Agents 51:4, pages 594-600.
Crossref
Crossref
S. A. M. Dhaese, V. Stove & J. J. De Waele. 2018. Annual Update in Intensive Care and Emergency Medicine 2018. Annual Update in Intensive Care and Emergency Medicine 2018
53
69
.
Thierry Calandra & Benoît Guery. 2018. Handbook of Sepsis. Handbook of Sepsis
185
199
.